There are 2949 resources available
872P - Comparison of colposcopy, pap smear test and visual inspection with acetic acid (VIA) as screening tests for precancer of the cervix (CIN2+) in high risk patients
Presenter: Zakaa Zawua
Session: E-Poster Display
Resources:
Abstract
873P - In vivo persistence of Iovance tumour-infiltrating lymphocytes LN-145 in cervical cancer patients
Presenter: Amir Jazaeri
Session: E-Poster Display
Resources:
Abstract
874P - Programmed death ligand - 1 (PD L-1) expression in cervical cancer patients
Presenter: Aryakrishna S L
Session: E-Poster Display
Resources:
Abstract
875P - Performance and diagnostic accuracy of human papillomavirus testing on urine and self-collected vaginal samples in a referral population
Presenter: Hyun-woong Cho
Session: E-Poster Display
Resources:
Abstract
876P - The effect of surgical techniques on sexuality and global quality of life (Qol) in women with ovarian germ cell (OGCT) and sex cord stromal tumours (SCST): An analysis of the AGO-CORSETT database
Presenter: Annette Hasenburg
Session: E-Poster Display
Resources:
Abstract
879TiP - Phase II study of bintrafusp alfa, a bifunctional fusion protein targeting TGF-β and PD-L1, in platinum-experienced advanced cervical cancer
Presenter: Michael Birrer
Session: E-Poster Display
Resources:
Abstract
880TiP - Randomized, open-label, phase II trial of dostarlimab (TSR-042), as maintenance therapy for patients with high-risk locally advanced cervical cancer after chemo-radiation: ATOMICC study
Presenter: Ana Oaknin
Session: E-Poster Display
Resources:
Abstract
881TiP - A multi-centre, open-label phase II trial of the combination of VB10.16 and atezolizumab in patients with advanced or recurrent, non-resectable HPV16 positive cervical cancer
Presenter: Peter Hillemanns
Session: E-Poster Display
Resources:
Abstract
882TiP - InnovaTV 208: New weekly dosing cohort in the phase II study of tisotumab vedotin in platinum-resistant ovarian cancer
Presenter: Stephanie Blank
Session: E-Poster Display
Resources:
Abstract
883TiP - MOONSTONE/GOG-3032: A phase II, open-label, single-arm study to evaluate the efficacy and safety of niraparib + dostarlimab in patients with platinum-resistant ovarian cancer
Presenter: Leslie Randall
Session: E-Poster Display
Resources:
Abstract